Immutep IMMP
NASDAQ IMMP
$0.36 -0.01 (-2.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Immutep (IMMP) Operating Leases (2019 - 2026)

Immutep's (IMMP) quarterly Operating Leases came in at $205818.2 in Q2 2026, up 56.47% on a YoY basis from $131538.6 in Q2 2025, and up 20.56% quarter-over-quarter from $170712.3 in Q4 2025.

Analysis

Immutep (IMMP) Operating Leases (2019 - 2026) Analysis & Trends

Immutep (IMMP) has reported Operating Leases for 8 consecutive years, with $205818.2 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Leases rose 56.47% year-over-year to $205818.2; the trailing twelve-month figure through Jun 2026 stood at $205818.2 (up 56.47% YoY), and the FY2026 full-year result was $205818.2, up 56.47% from the prior year.
  • Operating Leases climbed to $205818.2 in Q2 2026 per IMMP's latest filing, from $170712.3 in the prior quarter.
  • Across five years, Operating Leases topped out at $262546.7 in Q2 2023 and bottomed at $89851.7 in Q4 2022.
  • Historically, Operating Leases has averaged $169242.0 across 5 years, with a median of $170712.3 in 2025.
  • The sharpest annual moves came in 2022 and 2026: Operating Leases slumped 42.09% in 2022, then surged 56.47% in 2026.
  • Over 5 years, Operating Leases stood at $89851.7 in 2022, then soared by 52.23% to $136785.5 in 2023, then increased by 24.86% to $170787.3 in 2024, then fell by 0.04% to $170712.3 in 2025, then rose by 20.56% to $205818.2 in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $205818.2, $170712.3, and $131538.6 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Immutep 51.68 Mn 51.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 205,818.15
Dec 31, 2025 170,712.27
Jun 30, 2025 131,538.58
Dec 31, 2024 170,787.31
Jun 30, 2024 153,960.64
Dec 31, 2023 136,785.47
Jun 30, 2023 262,546.69
Dec 31, 2022 89,851.67
Jun 30, 2022 201,177.57
Dec 31, 2021 155,145.89
Jun 30, 2021 222,012.29
Dec 31, 2020 155,221.31
Jun 30, 2020 171,971.23
Dec 31, 2019 86,114.59
Jun 30, 2019 235,421.73